Health Catalyst to Participate in Upcoming Investor Conference

SALT LAKE CITY, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, including a presentation on Wednesday, January 15, 2025, at 10:30 am PT. The webcast link and related presentation materials will be available online at https://ir.healthcatalyst.com.

About Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations and is committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its clients leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Health Catalyst Investor Relations Contact:

Jack Knight
Vice President, Investor Relations
+1 (855) 309-6800
[email protected]

Health Catalyst Media Contact:

Amanda Flanders
Senior Vice President, Marketing and Communications
[email protected]  

You May Also Be Interested In

• Talisker Announces $11 Million Equipment Financing Facility to Fund Ore Sorting and Processing Equipment for the Bralorne Gold Project
• Clariant rejects Dow Europe’s allegations against four companies related to the 2020 competition law infringement
• Umicore - Transparency notification by Amundi SA